A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury. [electronic resource]
Producer: 20170524Description: 142-147 p. digitalISSN:- 1464-410X
- Adult
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Antioxidants -- therapeutic use
- Ascorbic Acid -- therapeutic use
- Calcium Channel Blockers -- therapeutic use
- Drug Therapy, Combination
- Female
- Humans
- Kidney -- injuries
- Lithotripsy -- adverse effects
- Losartan -- therapeutic use
- Male
- Selenium -- therapeutic use
- Verapamil -- therapeutic use
- Vitamin A -- therapeutic use
- Vitamin E -- therapeutic use
- Vitamins -- therapeutic use
- Wounds and Injuries -- prevention & control
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.